CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 135 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,327,241 | +35.7% | 1,161,964 | -0.5% | 0.01% | +50.0% |
Q2 2023 | $12,772,876 | +23.8% | 1,167,413 | -1.3% | 0.00% | +33.3% |
Q1 2023 | $10,318,742 | +125097.1% | 1,183,236 | -10.0% | 0.00% | +50.0% |
Q4 2022 | $8,242 | -99.8% | 1,314,522 | +5.4% | 0.00% | 0.0% |
Q3 2022 | $4,366,000 | +37.3% | 1,247,365 | +15.7% | 0.00% | +100.0% |
Q2 2022 | $3,179,000 | +8.6% | 1,077,686 | +14.5% | 0.00% | 0.0% |
Q1 2022 | $2,926,000 | +8.9% | 940,806 | +18.4% | 0.00% | 0.0% |
Q4 2021 | $2,686,000 | -5.4% | 794,841 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $2,840,000 | -43.9% | 778,115 | -33.0% | 0.00% | -50.0% |
Q2 2021 | $5,063,000 | -15.6% | 1,161,109 | -12.2% | 0.00% | 0.0% |
Q1 2021 | $6,002,000 | -16.5% | 1,322,192 | +5.6% | 0.00% | -33.3% |
Q4 2020 | $7,187,000 | -5.0% | 1,251,986 | +19.8% | 0.00% | 0.0% |
Q3 2020 | $7,563,000 | +138.1% | 1,044,735 | +14.8% | 0.00% | +200.0% |
Q2 2020 | $3,177,000 | +102.6% | 910,303 | -14.1% | 0.00% | 0.0% |
Q1 2020 | $1,568,000 | -26.9% | 1,059,531 | -3.1% | 0.00% | 0.0% |
Q4 2019 | $2,144,000 | -63.4% | 1,093,885 | -4.4% | 0.00% | -50.0% |
Q3 2019 | $5,860,000 | -26.6% | 1,144,516 | +2.6% | 0.00% | -33.3% |
Q2 2019 | $7,989,000 | -42.8% | 1,115,859 | +6.1% | 0.00% | -50.0% |
Q1 2019 | $13,971,000 | +147.6% | 1,052,066 | +46.7% | 0.01% | +100.0% |
Q4 2018 | $5,643,000 | +47.2% | 716,974 | +107.2% | 0.00% | +200.0% |
Q3 2018 | $3,834,000 | – | 345,989 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |